139 related articles for article (PubMed ID: 26077571)
1. Interferon regulatory factor signalings in cardiometabolic diseases.
Zhang XJ; Zhang P; Li H
Hypertension; 2015 Aug; 66(2):222-47. PubMed ID: 26077571
[No Abstract] [Full Text] [Related]
2. [Diabetes and the liver].
Herzig S; Roden M
Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
[No Abstract] [Full Text] [Related]
3. Selective insulin and leptin resistance in metabolic disorders.
Könner AC; Brüning JC
Cell Metab; 2012 Aug; 16(2):144-52. PubMed ID: 22883229
[TBL] [Abstract][Full Text] [Related]
4. Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.
Zhang Y; Zhang XJ; Li H
Curr Drug Targets; 2017; 18(15):1754-1778. PubMed ID: 26240052
[TBL] [Abstract][Full Text] [Related]
5. Heart rate recovery is associated with obesity traits and related cardiometabolic risk factors in children and adolescents.
Laguna M; Aznar S; Lara MT; Lucía A; Ruiz JR
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):995-1001. PubMed ID: 23211756
[TBL] [Abstract][Full Text] [Related]
6. Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors.
Woods SC
Am J Med; 2007 Mar; 120(3 Suppl 1):S19-25. PubMed ID: 17320518
[TBL] [Abstract][Full Text] [Related]
7. mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging.
Das A; Reis F; Maejima Y; Cai Z; Ren J
Oxid Med Cell Longev; 2017; 2017():6018675. PubMed ID: 28770023
[No Abstract] [Full Text] [Related]
8. Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance.
Wang XA; Zhang R; She ZG; Zhang XF; Jiang DS; Wang T; Gao L; Deng W; Zhang SM; Zhu LH; Guo S; Chen K; Zhang XD; Liu DP; Li H
Hepatology; 2014 Mar; 59(3):870-85. PubMed ID: 24123166
[TBL] [Abstract][Full Text] [Related]
9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis C virus-associated dysmetabolic syndrome.
Lonardo A; Loria P
Hepatology; 2008 Sep; 48(3):1018-9; author reply 1019. PubMed ID: 18756483
[No Abstract] [Full Text] [Related]
11. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
12. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and cardiovascular risk.
Brea A; Puzo J
Int J Cardiol; 2013 Aug; 167(4):1109-17. PubMed ID: 23141876
[TBL] [Abstract][Full Text] [Related]
14. Adipocytes and cardiometabolic risk.
Allende-Vigo MZ
Am J Ther; 2012 Jul; 19(4):294-9. PubMed ID: 21150766
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and cardiovascular disease.
McFarlane SI; Banerji M; Sowers JR
J Clin Endocrinol Metab; 2001 Feb; 86(2):713-8. PubMed ID: 11158035
[No Abstract] [Full Text] [Related]
16. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
17. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
18. Serving diabetes and cardiology: round three of the South African diabetologist/cardiologist debate.
Aalbers J
Cardiovasc J Afr; 2011; 22(3):161-3. PubMed ID: 21713308
[No Abstract] [Full Text] [Related]
19. The 'obesity paradox' may not be a paradox at all.
Banack HR; Stokes A
Int J Obes (Lond); 2017 Aug; 41(8):1162-1163. PubMed ID: 28584251
[No Abstract] [Full Text] [Related]
20. Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors.
Chang YC; Lin JW; Wang LC; Chen HM; Hwang JJ; Chuang LM
Eye (Lond); 2010 Jun; 24(6):1037-43. PubMed ID: 19816514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
